Kazatomprom maintains 2026 production and sales guidance but lowers revenue expectations and significantly raises cost forecasts

Overview

Based on the 1H26 results and 2026 guidance of Kazatomprom, the world's largest U3O8 producer, the report provides a supply, cost, and operational reference for the Americas uranium industry. The core conclusion is that production growth and a higher realized uranium price supported revenue, but higher mineral extraction taxes, sulfuric acid prices, tenge appreciation, and other cost pressures weakened profitability. Consequently, the company maintained its production and sales guidance while lowering revenue guidance and raising cost guidance.

Core views

First, Kazatomprom maintained its 2026 production and sales targets and did not raise full-year guidance despite strong year-over-year production growth in 1H26. The company maintained production guidance of 71.49mn-75.39mn lbs on a 100% basis and 37.70mn-40.30mn lbs on an attributable basis; consolidated sales volume guidance remained 50.70mn-53.30mn lbs, while KAP-level sales volume guidance remained 34.06mn-36.66mn lbs. In contrast to stable production and sales targets, financial guidance weakened: revenue guidance was lowered from KZT 2.2-2.3tn to KZT 2.1-2.2tn, C1 cash cost guidance was raised from $23.5-25.0/lb to $25.5-27.0/lb, and AISC guidance was raised from $35.0-36.5/lb to $39.0-40.5/lb. The company attributed the higher cost guidance to tenge appreciation, rising sulfuric acid prices, and increased wellfield development activity. 1H26 operating performance reflected a divergence between production growth and the pace of sales. Production on a 100% basis increased 9% year over year to 34.6mn lbs, while attributable production rose 10% year over year to 18.3mn lbs, mainly due to higher production plans and continued ramp-ups at projects including JV Inkai, JV Budenovskoye, and JV KATCO. Consolidated sales volume was broadly flat year over year at 19.7mn lbs, but KAP-level sales volume declined 13%, mainly due to changes in delivery timing and customer schedules. This indicates that production growth during the period did not translate concurrently into KAP-level sales growth, while higher inventories provided a buffer for subsequent deliveries: the group's finished goods inventory increased 23% year over year to 21.4mn lbs, and KAP inventory rose 15% year over year to 16.1mn lbs. The financial results show that the higher realized price was insufficient to fully offset cost and non-operating pressures. The realized uranium price increased 16% year over year, driving a 9% year-over-year increase in revenue to KZT 717.8bn; however, net profit declined 9% year over year to KZT 240.4bn, which the report attributed to higher foreign exchange losses and financing costs. Adjusted EBITDA increased only 2% year over year to KZT 371.3bn. During the same period, attributable C1 cash costs rose 37% year over year to $24.48/lb, while AISC increased 25% year over year to $38.45/lb, mainly due to Kazakhstan's differentiated mineral extraction tax regime, sulfuric acid cost inflation, and tenge appreciation; management also noted continued price increases for materials, equipment, and drilling services. Sulfuric acid costs rose 39% year over year during the period, making them a key monitoring variable explicitly identified in the report. Sulfuric acid supply and the progress of new facilities are important operational variables. Commissioning of the Taiqonyr Qyshqyl Zauyty (TQZ) sulfuric acid plant was postponed from the previous target of 1Q27 to 3Q27-1Q28 due to a suspension of regulatory work. Management stated that the delay is not currently expected to have a material impact on uranium production and continues to believe sulfuric acid supply will remain stable in 2026. Meanwhile, JV Inkai, JV Budenovskoye, and JV KATCO continued to ramp up; the new Zhalpak processing facility was commissioned in July with initial capacity of 500 tU/year and is planned to expand to 900 tU/year in 2027. These projects support the production plan, but costs and the supply of key inputs will continue to determine whether higher production translates into improved profitability. Finally, the company plans to convene an extraordinary general meeting of shareholders to approve two newly signed and previously undisclosed uranium transactions: a spot-term contract for natural uranium concentrates with State Nuclear Uranium Resource Development Company Limited (SNURDC), and a natural uranium (U3O8) supply contract with Uranium One Group. Management stated that the value of the relevant agreements exceeds one-quarter of Kazatomprom's standalone book value and noted that the approval threshold may relate to the two contracts in combination rather than either individual contract; the company did not disclose further terms due to confidentiality requirements. For the Americas uranium industry, Kazatomprom's results provide an important reference: supply growth, project ramp-ups, and inventory increases can coexist with significant cost inflation, and higher production does not necessarily generate commensurate profit growth.

Analysis framework

The report first assesses whether Kazatomprom adjusted its 2026 guidance for production, sales volume, revenue, and unit costs, and then compares 1H26 production, sales volume, realized prices, revenue, profit, EBITDA, and inventories with the prior-year period. It then breaks down changes in profitability into drivers including prices, volumes, taxes, sulfuric acid, exchange rates, financing costs, and project development activity, and evaluates the supply and cost trajectory in conjunction with operational events such as the sulfuric acid plant delay, mine and processing facility ramp-ups, and approval of new contracts.

Methodology notes

• Industry/Sector Analysis FrameworkVolume-price decomposition

  Decomposition of production, sales volume, and realized uranium price

  The report examines production, sales volume, and realized prices separately, explaining that revenue growth resulted from the higher realized uranium price, while KAP-level sales volume declined due to delivery timing and customer schedules, thereby avoiding attributing revenue changes simplistically to a single factor.

• Corporate Fundamentals and Financial FrameworkEarnings Quality Analysis

  Analysis of differences among revenue, adjusted EBITDA, and net profit

  The report compares the differing growth rates of revenue, adjusted EBITDA, and net profit, and combines them with foreign exchange losses, financing costs, and rising unit costs to explain why revenue growth did not translate into net profit growth.

• Industry/Sector Analysis FrameworkUpstream-Midstream-Downstream Value Chain Transmission

  Transmission of sulfuric acid and other input costs to uranium production costs

  The report links sulfuric acid prices, materials, equipment, drilling services, and wellfield development activity to C1 cash costs and AISC, while tracking the impact of sulfuric acid plant commissioning progress on input supply and production plans.

• Event Games and Behavioral FinanceEvent-driven analysis

  Analysis of earnings releases, guidance revisions, and contract approval events

  The report focuses on the 1H26 results release, compares the new and previous annual guidance, and analyzes subsequent monitoring milestones arising from the sulfuric acid plant delay and the submission of two new uranium contracts for approval at an extraordinary general meeting of shareholders.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Kazatomprom (KAP, not covered)

  The report uses its 1H26 results, 2026 guidance, and operational updates as a supply and cost reference for the Americas uranium industry.

  Strengths

  The world's largest U3O8 producer; 1H26 production growth; higher realized uranium price; increased inventories provide delivery flexibility; multiple projects continue to ramp up.

  Weaknesses

  Unit costs increased significantly, KAP-level sales volume declined, and net profit fell year over year despite revenue growth.

  Comparison

  The report does not provide a quantitative peer comparison with specific Americas uranium companies.

  Risks

  Mineral extraction taxes, sulfuric acid costs, tenge appreciation, inflation in materials and drilling services, foreign exchange losses, financing costs, and project delays may continue to constrain profitability.

Key data

• 2026 production guidance71.49mn-75.39mn lbs (100% basis); 37.70mn-40.30mn lbs (attributable basis)Unchanged
• 2026 sales volume guidance50.70mn-53.30mn lbs (consolidated basis); 34.06mn-36.66mn lbs (KAP level)Unchanged
• 2026 revenue guidanceKZT 2.1-2.2tnPreviously KZT 2.2-2.3tn
• 2026 C1 cash cost guidance$25.5-27.0/lbPreviously $23.5-25.0/lb
• 2026 AISC guidance$39.0-40.5/lbPreviously $35.0-36.5/lb
• 1H26 production34.6mn lbs (100% basis); 18.3mn lbs (attributable basis)Up 9% and 10% year over year, respectively
• 1H26 sales volume19.7mn lbs (consolidated basis)Broadly flat year over year; KAP-level sales volume declined 13% year over year
• 1H26 revenueKZT 717.8bnUp 9% year over year, with the realized uranium price rising 16% year over year
• 1H26 net profitKZT 240.4bnDown 9% year over year, affected by foreign exchange losses and higher financing costs
• 1H26 adjusted EBITDAKZT 371.3bnUp 2% year over year
• 1H26 inventory21.4mn lbs (group); 16.1mn lbs (KAP)Up 23% and 15% year over year, respectively
• 1H26 attributable C1 cash cost$24.48/lbUp 37% year over year
• 1H26 attributable AISC$38.45/lbUp 25% year over year
• Sulfuric acid costsUp 39% year over yearMineral extraction taxes, sulfuric acid costs, and tenge appreciation jointly drove unit costs higher
• TQZ sulfuric acid plant commissioning timeline3Q27-1Q28The previous target was 1Q27; management expects no material impact on uranium production
• Zhalpak processing facility capacityInitial 500 tU/year; planned expansion to 900 tU/year in 2027The facility was commissioned in July
• Scale of new uranium contractsMore than one-quarter of Kazatomprom's standalone book valueMay relate to the two contracts combined; further terms were not disclosed due to confidentiality

Impact & implications

The report believes Kazatomprom's results demonstrate both supply resilience and profitability pressure: mine ramp-ups, new processing facilities, and higher inventories support production and deliveries, but the company still did not raise its 2026 production and sales guidance; the higher realized uranium price drove revenue growth, but this was partly offset by taxes, sulfuric acid, exchange rates, and financing costs. As the world's largest U3O8 producer, the main reference its performance provides for the Americas uranium industry is that supply growth and cost inflation can occur simultaneously, and assessments of industry conditions must examine changes in production separately from changes in unit costs and profits.

Risks

• Higher differentiated mineral extraction taxes, sulfuric acid prices, tenge appreciation, and inflation in materials, equipment, and drilling services may continue to drive C1 cash costs and AISC higher.
• Foreign exchange losses and higher financing costs have already caused 1H26 net profit to decline 9% year over year despite revenue growth.
• The TQZ sulfuric acid plant was delayed to 3Q27-1Q28 due to a suspension of regulatory work, although management currently expects no material impact on uranium production.
• Changes in delivery timing and customer schedules may continue to cause production and KAP-level sales volume to diverge.

What to watch

• Track whether the 2026 production, sales volume, and revised revenue guidance can be achieved.
• Monitor the subsequent impact of sulfuric acid prices, differentiated mineral extraction taxes, and tenge movements on C1 cash costs and AISC.
• Monitor regulatory progress and the commissioning timeline for the TQZ sulfuric acid plant, as well as the stability of 2026 sulfuric acid supply as stated by management.
• Track the ramp-ups of JV Inkai, JV Budenovskoye, and JV KATCO, as well as the plan to expand the Zhalpak facility to 900 tU/year in 2027.
• Monitor the extraordinary general meeting's approval decisions on the two new uranium contracts and whether the company discloses further information such as contract size, duration, and delivery arrangements.